Avacta Life Sciences is a company dedicated to providing Life Scientists with proprietary, disruptive new tools, in the forms of technology and reagents, to enable them to work faster and smarter towards improvements to global healthcare. The company was formed in 2006 and is now commercializing its services and first products, Optim and Sensipod through two business units, Avacta Analytical and Avacta Animal Health. Avacta's products, including Optim and Sensipod, are helping Life Scientists reduce the risk of drug development, make drugs cheaper for patients, and improve diagnoses at the point-of-care. Additionally, the company has acquired intellectual property relating to Affimers - an alternative to antibodies, with a large market opportunity in general Life Sciences R&D, diagnostics, and therapeutics. Avacta is focusing its resources on providing affinity reagents for general Life Sciences R&D and protein microarrays for drug and biomarker discovery. The company's Affimer technology has the potential to revolutionize the life sciences industry and can be used for a wide range of applications in diagnostics, drug/biomarker discovery, biotech research & development, and as therapeutic agents. For more information, visit www.avactalifesciences.com.
Show More